Every review of these trials I read did not conclude the drug was responsible. That's why I said the stuff in the press was "unfortunate." However, the trial protocol clearly (in my view) was responsible. They took too much blood out and what they put back was not a suitable replacement. That's not the drug's fault, it's the protocol's fault.
Market Data 
Markets 
AI
